Offer - Urjas Oil for just ₹ 1 X
Esgipyrin 50/325 Tablet (15) is a prescription medicine that is available as a Tablet. Other than this, Esgipyrin 50/325 Tablet (15) has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Esgipyrin 50/325 Tablet (15) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Esgipyrin 50/325 Tablet (15) also has some side effects, the most common being Abdominal Pain, Nausea or vomiting, Diarrhoea. Apart from the aforementioned side effects, Esgipyrin 50/325 Tablet (15) can also lead to other problems, which have been listed below. Usually, these side effects of Esgipyrin 50/325 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Esgipyrin 50/325 Tablet (15)'s effect during pregnancy is Mild and Mild while nursing. In addition, Esgipyrin 50/325 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Esgipyrin 50/325 Tablet (15) related warnings section.
Esgipyrin 50/325 Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Kidney Disease, Heart Attack are examples of such conditions.
Additionally, Esgipyrin 50/325 Tablet (15) may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Esgipyrin 50/325 Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Esgipyrin 50/325 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Esgipyrin 50/325 Tablet (15) safe for pregnant women?
Esgipyrin has little to no side effects in pregnant women.
Is the use of Esgipyrin 50/325 Tablet (15) safe during breastfeeding?
Breastfeeding women can take Esgipyrin as it bears very minor side effects for them.
What is the effect of Esgipyrin 50/325 Tablet (15) on the Kidneys?
There may be some adverse effects on kidney after taking Esgipyrin. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Esgipyrin 50/325 Tablet (15) on the Liver?
The liver can be affected by Esgipyrin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Esgipyrin only after medical advice.
What is the effect of Esgipyrin 50/325 Tablet (15) on the Heart?
Esgipyrin may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Esgipyrin 50/325 Tablet (15) unless your doctor advises you to do so -
Is this Esgipyrin 50/325 Tablet (15) habit forming or addictive?
Esgipyrin 50/325 Tablet (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Esgipyrin 50/325 Tablet (15) as you may feel sleepy.
Is it safe?
Yes, but consume Esgipyrin 50/325 Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
No, Esgipyrin 50/325 Tablet (15) cannot treat any kind of mental disorder.
Interaction between Food and Esgipyrin 50/325 Tablet (15)
Taking Esgipyrin 50/325 Tablet (15) with food is safe.
Interaction between Alcohol and Esgipyrin 50/325 Tablet (15)
Information about the interaction of Esgipyrin 50/325 Tablet (15) and alcohol is not currently available because this topic has not been researched yet.
No, Esgipyrin should not be taken in Dengue because it can increase the risk of internal bleeding. Patients should consult a medical professional, take ample rest and drink plenty of fluids. However, paracetamol can be taken to bring down fever and reduce joint aches.
Yes, Esgipyrin can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Esgipyrin is a prescription drug so do not take it without consulting a doctor. It can be harmful for people to take this medicine without a doctor's recommendation.
Yes, Esgipyrin is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects have been observed such as epigastric pain (stomach pain), nausea, headache, dizziness, rashes, gastric ulceration, and bleeding are less common.
Yes, you can take Esgipyrin for a headache. This drug blocks the pain sensitizing mechanism induced by bradykinin (an inflammatory mediator).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)